31 octubre 2014
A study of pediatric patients with hepatoblastoma suggests an opportunity to reduce chemotherapy in up to 65 percent of patients, which could lead to a decrease in the incidence of adverse effects, experts say.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/EuPNSIEz9RY/141030213704.htm
